**Core Concept**
The management of **status epilepticus** requires immediate intervention to prevent neurological damage. Intravenous anaesthetic agents are used to rapidly control seizures. The choice of agent depends on its ability to quickly terminate seizures with minimal side effects.

**Why the Correct Answer is Right**
In the context of status epilepticus, the intravenous anaesthetic agent of choice is often **midazolam** due to its rapid onset of action, efficacy in terminating seizures, and relatively favorable safety profile. Midazolam acts on the **GABA_A receptor**, enhancing the inhibitory effects of **GABA** and thus reducing neuronal excitability.

**Why Each Wrong Option is Incorrect**
**Option A:** Other benzodiazepines like diazepam can be used but midazolam is preferred for its pharmacokinetic profile.
**Option B:** Propofol is used in refractory status epilepticus but not as the first-line due to its potential for significant respiratory depression.
**Option D:** Barbiturates can be effective but are typically reserved for cases where other agents fail due to their side effect profile.

**Clinical Pearl / High-Yield Fact**
In status epilepticus, timely administration of an effective intravenous anaesthetic agent is crucial to prevent long-term neurological damage. Midazolam's ease of administration and rapid effect make it a preferred initial choice.

**Correct Answer:** D. Midazolam